<DOC>
	<DOCNO>NCT01254344</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ertapenem sodium compare ceftriaxone sodium/metronidazole prophylaxis surgical site infection follow elective colorectal surgery Chinese adult . This study design demonstrate ertapenem sodium non-inferior ceftriaxone sodium/metronidazole participant population .</brief_summary>
	<brief_title>Efficacy Safety Ertapenem Sodium ( MK-0826 ) Following Colorectal Surgery Chinese Adults ( MK-0826-056 )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Participant schedule undergo elective colon colorectal surgery laparotomy schedule advance adequate time prior surgery complete preoperative bowel preparation . Participant Chinese adult age 18 year old less 81 year old . Participant highly unlikely conceive . Participant undergoing emergency colon colorectal surgery . Participant require second planned colorectal surgery surgery require antibiotic prophylaxis within 4week followup period . Participant undergoing laparoscopicassisted surgery . Participant undergo isolated rectal procedure . Participant decompensated intestinal obstruction . Participant active inflammatory bowel disease involve colon ( i.e. , ulcerative colitis Crohn 's disease ) . Participant schedule undergo elective colorectal procedure revision previous operation involve large bowel resection . Participant bacterial infection time surgery . Participant require anticipate need administration ( nonstudy therapy ) systemic antimicrobial therapy within 1 week prior surgery time study . Participant anticipate receive either antibiotic antiseptic peritoneal lavage surgery . Participant history serious allergy , hypersensitivity ( e.g. , anaphylaxis ) , serious reaction ertapenem sodium , ceftriaxone sodium , metronidazole , penicillin , cephalosporin , beta ( Î² ) lactam , nitroimidazole agent . Participant breast feed plan breast feed prior completion study period . Participant neutropenia . Participant immunosuppression due underlying disease , chronic immunosuppressive therapy , use highdose corticosteroid . Participant rapidly progressive terminal illness . Participant consider unlikely survive expect 4week study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Colorectal surgery</keyword>
</DOC>